United States OTC Drug Market Report 2017

United States OTC Drug Market Report 2017

1 OTC Drug Overview

1.1 Product Overview and Scope of OTC Drug

1.2 Classification of OTC Drug by Product Category

1.2.1 United States OTC Drug Market Size (Sales Volume) Comparison by Type (2012-2022)

1.2.2 United States OTC Drug Market Size (Sales Volume) Market Share by Type (Product Category) in 2016

1.2.3 Class A

1.2.4 Class B

1.3 United States OTC Drug Market by Application/End Users

1.3.1 United States OTC Drug Market Size (Consumption) and Market Share Comparison by Application (2012-2022)

1.3.2 Hospital

1.3.3 Clinic

1.3.4 Household

1.4 United States OTC Drug Market by Region

1.4.1 United States OTC Drug Market Size (Value) Comparison by Region (2012-2022)

1.4.2 The West OTC Drug Status and Prospect (2012-2022)

1.4.3 Southwest OTC Drug Status and Prospect (2012-2022)

1.4.4 The Middle Atlantic OTC Drug Status and Prospect (2012-2022)

1.4.5 New England OTC Drug Status and Prospect (2012-2022)

1.4.6 The South OTC Drug Status and Prospect (2012-2022)

1.4.7 The Midwest OTC Drug Status and Prospect (2012-2022)

1.5 United States Market Size (Value and Volume) of OTC Drug (2012-2022)

1.5.1 United States OTC Drug Sales and Growth Rate (2012-2022)

1.5.2 United States OTC Drug Revenue and Growth Rate (2012-2022)

2 United States OTC Drug Market Competition by Players/Suppliers

2.1 United States OTC Drug Sales and Market Share of Key Players/Suppliers (2012-2017)

2.2 United States OTC Drug Revenue and Share by Players/Suppliers (2012-2017)

2.3 United States OTC Drug Average Price by Players/Suppliers (2012-2017)

2.4 United States OTC Drug Market Competitive Situation and Trends

2.4.1 United States OTC Drug Market Concentration Rate

2.4.2 United States OTC Drug Market Share of Top 3 and Top 5 Players/Suppliers

2.4.3 Mergers & Acquisitions, Expansion in United States Market

2.5 United States Players/Suppliers OTC Drug Manufacturing Base Distribution, Sales Area, Product Type

3 United States OTC Drug Sales (Volume) and Revenue (Value) by Region (2012-2017)

3.1 United States OTC Drug Sales and Market Share by Region (2012-2017)

3.2 United States OTC Drug Revenue and Market Share by Region (2012-2017)

3.3 United States OTC Drug Price by Region (2012-2017)

4 United States OTC Drug Sales (Volume) and Revenue (Value) by Type (Product Category) (2012-2017)

4.1 United States OTC Drug Sales and Market Share by Type (Product Category) (2012-2017)

4.2 United States OTC Drug Revenue and Market Share by Type (2012-2017)

4.3 United States OTC Drug Price by Type (2012-2017)

4.4 United States OTC Drug Sales Growth Rate by Type (2012-2017)

5 United States OTC Drug Sales (Volume) by Application (2012-2017)

5.1 United States OTC Drug Sales and Market Share by Application (2012-2017)

5.2 United States OTC Drug Sales Growth Rate by Application (2012-2017)

5.3 Market Drivers and Opportunities

6 United States OTC Drug Players/Suppliers Profiles and Sales Data

6.1 Bayer HealthCare

6.1.1 Company Basic Information, Manufacturing Base and Competitors

6.1.2 OTC Drug Product Category, Application and Specification

6.1.2.1 Product A

6.1.2.2 Product B

6.1.3 Bayer HealthCare OTC Drug Sales, Revenue, Price and Gross Margin (2012-2017)

6.1.4 Main Business/Business Overview

6.2 GlaxoSmithKline (GSK)

6.2.2 OTC Drug Product Category, Application and Specification

6.2.2.1 Product A

6.2.2.2 Product B

6.2.3 GlaxoSmithKline (GSK) OTC Drug Sales, Revenue, Price and Gross Margin (2012-2017)

6.2.4 Main Business/Business Overview

6.3 Johnson&Johnson

6.3.2 OTC Drug Product Category, Application and Specification

6.3.2.1 Product A

6.3.2.2 Product B

6.3.3 Johnson&Johnson OTC Drug Sales, Revenue, Price and Gross Margin (2012-2017)

6.3.4 Main Business/Business Overview

6.4 Pfizer

6.4.2 OTC Drug Product Category, Application and Specification

6.4.2.1 Product A

6.4.2.2 Product B

6.4.3 Pfizer OTC Drug Sales, Revenue, Price and Gross Margin (2012-2017)

6.4.4 Main Business/Business Overview

6.5 Sanofi

6.5.2 OTC Drug Product Category, Application and Specification

6.5.2.1 Product A

6.5.2.2 Product B

6.5.3 Sanofi OTC Drug Sales, Revenue, Price and Gross Margin (2012-2017)

6.5.4 Main Business/Business Overview

6.6 AstraZeneca

6.6.2 OTC Drug Product Category, Application and Specification

6.6.2.1 Product A

6.6.2.2 Product B

6.6.3 AstraZeneca OTC Drug Sales, Revenue, Price and Gross Margin (2012-2017)

6.6.4 Main Business/Business Overview

6.7 BioGaia

6.7.2 OTC Drug Product Category, Application and Specification

6.7.2.1 Product A

6.7.2.2 Product B

6.7.3 BioGaia OTC Drug Sales, Revenue, Price and Gross Margin (2012-2017)

6.7.4 Main Business/Business Overview

6.8 Bristol Myers Squibb

6.8.2 OTC Drug Product Category, Application and Specification

6.8.2.1 Product A

6.8.2.2 Product B

6.8.3 Bristol Myers Squibb OTC Drug Sales, Revenue, Price and Gross Margin (2012-2017)

6.8.4 Main Business/Business Overview

6.9 Bukwang Pharmaceutica

6.9.2 OTC Drug Product Category, Application and Specification

6.9.2.1 Product A

6.9.2.2 Product B

6.9.3 Bukwang Pharmaceutica OTC Drug Sales, Revenue, Price and Gross Margin (2012-2017)

6.9.4 Main Business/Business Overview

6.10 Chr. Hansen

6.10.2 OTC Drug Product Category, Application and Specification

6.10.2.1 Product A

6.10.2.2 Product B

6.10.3 Chr. Hansen OTC Drug Sales, Revenue, Price and Gross Margin (2012-2017)

6.10.4 Main Business/Business Overview

6.11 Cipla

6.12 CoLucid

6.13 Daiichi Sankyo

6.14 Friggs

6.15 DSM

6.16 Eisai

6.17 Eli Lilly

6.18 Herbalife

6.19 Euradite

7 OTC Drug Manufacturing Cost Analysis

7.1 OTC Drug Key Raw Materials Analysis

7.1.1 Key Raw Materials

7.1.2 Price Trend of Key Raw Materials

7.1.3 Key Suppliers of Raw Materials

7.1.4 Market Concentration Rate of Raw Materials

7.2 Proportion of Manufacturing Cost Structure

7.2.1 Raw Materials

7.2.2 Labor Cost

7.2.3 Manufacturing Expenses

7.3 Manufacturing Process Analysis of OTC Drug

8 Industrial Chain, Sourcing Strategy and Downstream Buyers

8.1 OTC Drug Industrial Chain Analysis

8.2 Upstream Raw Materials Sourcing

8.3 Raw Materials Sources of OTC Drug Major Manufacturers in 2016

8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders

9.1 Marketing Channel

9.1.1 Direct Marketing

9.1.2 Indirect Marketing

9.1.3 Marketing Channel Development Trend

9.2 Market Positioning

9.2.1 Pricing Strategy

9.2.2 Brand Strategy

9.2.3 Target Client

9.3 Distributors/Traders List

10 Market Effect Factors Analysis

10.1 Technology Progress/Risk

10.1.1 Substitutes Threat

10.1.2 Technology Progress in Related Industry

10.2 Consumer Needs/Customer Preference Change

10.3 Economic/Political Environmental Change

11 United States OTC Drug Market Size (Value and Volume) Forecast (2017-2022)

11.1 United States OTC Drug Sales Volume, Revenue Forecast (2017-2022)

11.2 United States OTC Drug Sales Volume Forecast by Type (2017-2022)

11.3 United States OTC Drug Sales Volume Forecast by Application (2017-2022)

11.4 United States OTC Drug Sales Volume Forecast by Region (2017-2022)

12 Research Findings and Conclusion

13 Appendix

13.1 Methodology/Research Approach

13.1.1 Research Programs/Design

13.1.2 Market Size Estimation

13.1.3 Market Breakdown and Data Triangulation

13.2 Data Source

13.2.1 Secondary Sources

13.2.2 Primary Sources

13.3 Disclaimer

Figure Product Picture of OTC Drug

Figure United States OTC Drug Market Size (K Pcs) by Type (2012-2022)

Figure United States OTC Drug Sales Volume Market Share by Type (Product Category) in 2016

Figure Class A Product Picture

Figure Class B Product Picture

Figure United States OTC Drug Market Size (K Pcs) by Application (2012-2022)

Figure United States Sales Market Share of OTC Drug by Application in 2016

Figure Hospital Examples

Table Key Downstream Customer in Hospital

Figure Clinic Examples

Table Key Downstream Customer in Clinic

Figure Household Examples

Table Key Downstream Customer in Household

Figure United States OTC Drug Market Size (Million USD) by Region (2012-2022)

Figure The West OTC Drug Revenue (Million USD) and Growth Rate (2012-2022)

Figure Southwest OTC Drug Revenue (Million USD) and Growth Rate (2012-2022)

Figure The Middle Atlantic OTC Drug Revenue (Million USD) and Growth Rate (2012-2022)

Figure New England OTC Drug Revenue (Million USD) and Growth Rate (2012-2022)

Figure The South of US OTC Drug Revenue (Million USD) and Growth Rate (2012-2022)

Figure The Midwest OTC Drug Revenue (Million USD) and Growth Rate (2012-2022)

Figure United States OTC Drug Sales (K Pcs) and Growth Rate (2012-2022)

Figure United States OTC Drug Revenue (Million USD) and Growth Rate (2012-2022)

Figure United States OTC Drug Market Major Players Product Sales Volume (K Pcs) (2012-2017)

Table United States OTC Drug Sales (K Pcs) of Key Players/Suppliers (2012-2017)

Table United States OTC Drug Sales Share by Players/Suppliers (2012-2017)

Figure 2016 United States OTC Drug Sales Share by Players/Suppliers

Figure 2017 United States OTC Drug Sales Share by Players/Suppliers

Figure United States OTC Drug Market Major Players Product Revenue (Million USD) (2012-2017)

Table United States OTC Drug Revenue (Million USD) by Players/Suppliers (2012-2017)

Table United States OTC Drug Revenue Share by Players/Suppliers (2012-2017)

Figure 2016 United States OTC Drug Revenue Share by Players/Suppliers

Figure 2017 United States OTC Drug Revenue Share by Players/Suppliers

Table United States Market OTC Drug Average Price (USD/Pcs) of Key Players/Suppliers (2012-2017)

Figure United States Market OTC Drug Average Price (USD/Pcs) of Key Players/Suppliers in 2016

Figure United States OTC Drug Market Share of Top 3 Players/Suppliers

Figure United States OTC Drug Market Share of Top 5 Players/Suppliers

Table United States Players/Suppliers OTC Drug Manufacturing Base Distribution and Sales Area

Table United States Players/Suppliers OTC Drug Product Category

Table United States OTC Drug Sales (K Pcs) by Region (2012-2017)

Table United States OTC Drug Sales Share by Region (2012-2017)

Figure United States OTC Drug Sales Share by Region (2012-2017)

Figure United States OTC Drug Sales Market Share by Region in 2016

Table United States OTC Drug Revenue (Million USD) and Market Share by Region (2012-2017)

Table United States OTC Drug Revenue Share by Region (2012-2017)

Figure United States OTC Drug Revenue Market Share by Region (2012-2017)

Figure United States OTC Drug Revenue Market Share by Region in 2016

Table United States OTC Drug Price (USD/Pcs) by Region (2012-2017)

Table United States OTC Drug Sales (K Pcs) by Type (2012-2017)

Table United States OTC Drug Sales Share by Type (2012-2017)

Figure United States OTC Drug Sales Share by Type (2012-2017)

Figure United States OTC Drug Sales Market Share by Type in 2016

Table United States OTC Drug Revenue (Million USD) and Market Share by Type (2012-2017)

Table United States OTC Drug Revenue Share by Type (2012-2017)

Figure Revenue Market Share of OTC Drug by Type (2012-2017)

Figure Revenue Market Share of OTC Drug by Type in 2016

Table United States OTC Drug Price (USD/Pcs) by Types (2012-2017)

Figure United States OTC Drug Sales Growth Rate by Type (2012-2017)

Table United States OTC Drug Sales (K Pcs) by Application (2012-2017)

Table United States OTC Drug Sales Market Share by Application (2012-2017)

Figure United States OTC Drug Sales Market Share by Application (2012-2017)

Figure United States OTC Drug Sales Market Share by Application in 2016

Table United States OTC Drug Sales Growth Rate by Application (2012-2017)

Figure United States OTC Drug Sales Growth Rate by Application (2012-2017)

Table Bayer HealthCare Basic Information List

Table Bayer HealthCare OTC Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)

Figure Bayer HealthCare OTC Drug Sales Growth Rate (2012-2017)

Figure Bayer HealthCare OTC Drug Sales Market Share in United States (2012-2017)

Figure Bayer HealthCare OTC Drug Revenue Market Share in United States (2012-2017)

Table GlaxoSmithKline (GSK) Basic Information List

Table GlaxoSmithKline (GSK) OTC Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)

Figure GlaxoSmithKline (GSK) OTC Drug Sales Growth Rate (2012-2017)

Figure GlaxoSmithKline (GSK) OTC Drug Sales Market Share in United States (2012-2017)

Figure GlaxoSmithKline (GSK) OTC Drug Revenue Market Share in United States (2012-2017)

Table Johnson&Johnson Basic Information List

Table Johnson&Johnson OTC Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)

Figure Johnson&Johnson OTC Drug Sales Growth Rate (2012-2017)

Figure Johnson&Johnson OTC Drug Sales Market Share in United States (2012-2017)

Figure Johnson&Johnson OTC Drug Revenue Market Share in United States (2012-2017)

Table Pfizer Basic Information List

Table Pfizer OTC Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)

Figure Pfizer OTC Drug Sales Growth Rate (2012-2017)

Figure Pfizer OTC Drug Sales Market Share in United States (2012-2017)

Figure Pfizer OTC Drug Revenue Market Share in United States (2012-2017)

Table Sanofi Basic Information List

Table Sanofi OTC Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)

Figure Sanofi OTC Drug Sales Growth Rate (2012-2017)

Figure Sanofi OTC Drug Sales Market Share in United States (2012-2017)

Figure Sanofi OTC Drug Revenue Market Share in United States (2012-2017)

Table AstraZeneca Basic Information List

Table AstraZeneca OTC Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)

Figure AstraZeneca OTC Drug Sales Growth Rate (2012-2017)

Figure AstraZeneca OTC Drug Sales Market Share in United States (2012-2017)

Figure AstraZeneca OTC Drug Revenue Market Share in United States (2012-2017)

Table BioGaia Basic Information List

Table BioGaia OTC Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)

Figure BioGaia OTC Drug Sales Growth Rate (2012-2017)

Figure BioGaia OTC Drug Sales Market Share in United States (2012-2017)

Figure BioGaia OTC Drug Revenue Market Share in United States (2012-2017)

Table Bristol Myers Squibb Basic Information List

Table Bristol Myers Squibb OTC Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)

Figure Bristol Myers Squibb OTC Drug Sales Growth Rate (2012-2017)

Figure Bristol Myers Squibb OTC Drug Sales Market Share in United States (2012-2017)

Figure Bristol Myers Squibb OTC Drug Revenue Market Share in United States (2012-2017)

Table Bukwang Pharmaceutica Basic Information List

Table Bukwang Pharmaceutica OTC Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)

Figure Bukwang Pharmaceutica OTC Drug Sales Growth Rate (2012-2017)

Figure Bukwang Pharmaceutica OTC Drug Sales Market Share in United States (2012-2017)

Figure Bukwang Pharmaceutica OTC Drug Revenue Market Share in United States (2012-2017)

Table Chr. Hansen Basic Information List

Table Chr. Hansen OTC Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)

Figure Chr. Hansen OTC Drug Sales Growth Rate (2012-2017)

Figure Chr. Hansen OTC Drug Sales Market Share in United States (2012-2017)

Figure Chr. Hansen OTC Drug Revenue Market Share in United States (2012-2017)

Table Cipla Basic Information List

Table CoLucid Basic Information List

Table Daiichi Sankyo Basic Information List

Table Friggs Basic Information List

Table DSM Basic Information List

Table Eisai Basic Information List

Table Eli Lilly Basic Information List

Table Herbalife Basic Information List

Table Euradite Basic Information List

Table Production Base and Market Concentration Rate of Raw Material

Figure Price Trend of Key Raw Materials

Table Key Suppliers of Raw Materials

Figure Manufacturing Cost Structure of OTC Drug

Figure Manufacturing Process Analysis of OTC Drug

Figure OTC Drug Industrial Chain Analysis

Table Raw Materials Sources of OTC Drug Major Players/Suppliers in 2016

Table Major Buyers of OTC Drug

Table Distributors/Traders List

Figure United States OTC Drug Sales Volume (K Pcs) and Growth Rate Forecast (2017-2022)

Figure United States OTC Drug Revenue (Million USD) and Growth Rate Forecast (2017-2022)

Figure United States OTC Drug Price (USD/Pcs) Trend Forecast (2017-2022)

Table United States OTC Drug Sales Volume (K Pcs) Forecast by Type (2017-2022)

Figure United States OTC Drug Sales Volume (K Pcs) Forecast by Type (2017-2022)

Figure United States OTC Drug Sales Volume (K Pcs) Forecast by Type in 2022

Table United States OTC Drug Sales Volume (K Pcs) Forecast by Application (2017-2022)

Figure United States OTC Drug Sales Volume (K Pcs) Forecast by Application (2017-2022)

Figure United States OTC Drug Sales Volume (K Pcs) Forecast by Application in 2022

Table United States OTC Drug Sales Volume (K Pcs) Forecast by Region (2017-2022)

Table United States OTC Drug Sales Volume Share Forecast by Region (2017-2022)

Figure United States OTC Drug Sales Volume Share Forecast by Region (2017-2022)

Figure United States OTC Drug Sales Volume Share Forecast by Region in 2022

Table Research Programs/Design for This Report

Figure Bottom-up and Top-down Approaches for This Report

Figure Data Triangulation

Table Key Data Information from Secondary Sources

Table Key Data Information from Primary Sources